Literature DB >> 27162890

The Effects of Oltipraz on Tissue Regeneration in the Process of Wound Healing: A Stereological Study.

Ali Noorafshan1, Sina Kardeh2, Soheil Ashkani-Esfahani2, Mohammad Reza Namazi3, Ehsan Saleh2.   

Abstract

OBJECTIVE: To determine the effects of topical administration of 20% oltipraz solution on histomorphometrical and stereological aspects of skin tissue in full thickness skin wounds in laboratory rats.
METHODS: Thirty-six male Wistar portion rats (220±20 g) were randomly divided into three groups (n=12). On the first day of experimentation, a 1-cm2 circular wound was made on the posterior surface of neck in all rats by removing a full thickness skin piece immediately after induction of anesthesia with ether inhalation. One group was treated with vehicle solution (DMSO alone). The second group was treated daily with 20% oltipraz solution, and the third group, the control group, received no treatment. The wound closure rate was estimated our previously described method. The volume density of collagen bundles, vessels, and hair follicles, the vessels' length density, mean diameter of vessels and also fibroblast population were estimated by using stereological methods.
RESULTS: The oltipraz group indicated a significantly higher improvement (6.26% of the wound surface per day) than control and the vehicle treated groups (p=0.032); furthermore, there was inconsiderable difference between the rate of wound closure in the group treated with vehicle (4.93% per day) and the control group (4.43% per day).
CONCLUSION: Oltipraz  has  positive  influence on  fibroblast proliferation  and  re-pithelization.  A  noticeable observation in our study was absence of scar formation in wounds which were treated by oltipraz and can be mentioned as an advantage of this drug.

Entities:  

Keywords:  ; Wound Healing; Oltipraz; Rat; Stereology

Year:  2014        PMID: 27162890      PMCID: PMC4771292     

Source DB:  PubMed          Journal:  Bull Emerg Trauma        ISSN: 2322-2522


  24 in total

Review 1.  Infections.

Authors:  Brendan Healy; Andrew Freedman
Journal:  BMJ       Date:  2006-04-08

Review 2.  The impact of psychological stress on wound healing: methods and mechanisms.

Authors:  Jean-Philippe Gouin; Janice K Kiecolt-Glaser
Journal:  Immunol Allergy Clin North Am       Date:  2011-02       Impact factor: 3.479

Review 3.  Antioxidant therapies for wound healing: a clinical guide to currently commercially available products.

Authors:  S D Fitzmaurice; R K Sivamani; R R Isseroff
Journal:  Skin Pharmacol Physiol       Date:  2011-01-15       Impact factor: 3.479

4.  Oltipraz-induced phase 2 enzyme response conserved in cells lacking mitochondrial DNA.

Authors:  Yee Liu Chua; Dawei Zhang; Urs Boelsterli; Philip K Moore; Matthew Whiteman; Jeffrey S Armstrong
Journal:  Biochem Biophys Res Commun       Date:  2005-11-11       Impact factor: 3.575

5.  Modulation of gene expression in subjects at risk for colorectal cancer by the chemopreventive dithiolethione oltipraz.

Authors:  P J O'Dwyer; C E Szarka; K S Yao; T C Halbherr; G R Pfeiffer; F Green; J M Gallo; J Brennan; H Frucht; E B Goosenberg; T C Hamilton; S Litwin; A M Balshem; P F Engstrom; M L Clapper
Journal:  J Clin Invest       Date:  1996-09-01       Impact factor: 14.808

6.  Safety and efficacy of weekly oral oltipraz in chronic smokers.

Authors:  Michael J Kelley; Elizabeth M Glaser; James E Herndon; Frank Becker; Rajesh Bhagat; Yu-Jing Zhang; Regina M Santella; Steven G Carmella; Stephen S Hecht; Lilia Gallot; Lawrence Schilder; James A Crowell; Marjorie Perloff; Rodney J Folz; Raymond C Bergan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-04       Impact factor: 4.254

7.  The phase 2 enzyme inducers ethacrynic acid, DL-sulforaphane, and oltipraz inhibit lipopolysaccharide-induced high-mobility group box 1 secretion by RAW 264.7 cells.

Authors:  Meaghan E Killeen; Joshua A Englert; Donna Beer Stolz; Mingchen Song; Yusheng Han; Russell L Delude; John A Kellum; Mitchell P Fink
Journal:  J Pharmacol Exp Ther       Date:  2005-12-28       Impact factor: 4.030

8.  Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin.

Authors:  Yoo Ri Kim; Ji Eun Oh; Min Sung Kim; Mi Ran Kang; Sang Wook Park; Ji Youn Han; Hyeon Seok Eom; Nam Jin Yoo; Sug Hyung Lee
Journal:  J Pathol       Date:  2010-03       Impact factor: 7.996

9.  Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound.

Authors:  Susanne Braun; Christine Hanselmann; Marcus G Gassmann; Ulrich auf dem Keller; Christiane Born-Berclaz; Kaimin Chan; Yuet Wai Kan; Sabine Werner
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

10.  Phase 2 enzyme induction by the major metabolite of oltipraz.

Authors:  Jacobus P Petzer; Mettachit Navamal; Jesse K Johnson; Mi-Kyoung Kwak; Thomas W Kensler; James C Fishbein
Journal:  Chem Res Toxicol       Date:  2003-11       Impact factor: 3.739

View more
  5 in total

Review 1.  International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors.

Authors:  Csaba Szabo; Andreas Papapetropoulos
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

2.  Effect of Topical Morphine on Cutaneous Leishmaniasis in an Animal Model: A Preliminary Report.

Authors:  Fariborz Ghaffarpasand; Afsoon Akbarzadeh; Hamid Reza Heiran; Ali Asghar Karimi; Armin Akbarzadeh; Mohamed Amin Ghobadifar
Journal:  Iran Red Crescent Med J       Date:  2016-05-11       Impact factor: 0.611

3.  Oltipraz Prevents High Glucose-Induced Oxidative Stress and Apoptosis in RSC96 Cells through the Nrf2/NQO1 Signalling Pathway.

Authors:  Zengxin Jiang; Mengxuan Bian; Jingping Wu; Defang Li; Lei Ding; Qingmin Zeng
Journal:  Biomed Res Int       Date:  2020-06-23       Impact factor: 3.411

4.  Analgesic and Antidepressant Effects of Oltipraz on Neuropathic Pain in Mice by Modulating Microglial Activation.

Authors:  Andrés Felipe Díaz; Sara Polo; Núria Gallardo; Sergi Leánez; Olga Pol
Journal:  J Clin Med       Date:  2019-06-21       Impact factor: 4.241

Review 5.  Common Drug Pipelines for the Treatment of Diabetic Nephropathy and Hepatopathy: Can We Kill Two Birds with One Stone?

Authors:  Yoshio Sumida; Masashi Yoneda; Hidenori Toyoda; Satoshi Yasuda; Toshifumi Tada; Hideki Hayashi; Yoichi Nishigaki; Yusuke Suzuki; Takafumi Naiki; Asahiro Morishita; Hiroshi Tobita; Shuichi Sato; Naoto Kawabe; Shinya Fukunishi; Tadashi Ikegami; Takaomi Kessoku; Yuji Ogawa; Yasushi Honda; Takashi Nakahara; Kensuke Munekage; Tsunehiro Ochi; Koji Sawada; Atsushi Takahashi; Taeang Arai; Tomomi Kogiso; Satoshi Kimoto; Kengo Tomita; Kazuo Notsumata; Michihiro Nonaka; Kazuhito Kawata; Taro Takami; Takashi Kumada; Eiichi Tomita; Takeshi Okanoue; Atsushi Nakajima
Journal:  Int J Mol Sci       Date:  2020-07-13       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.